Loading...

Emerging Therapies in Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is a rare autoimmune disorder caused by peripheral platelet destruction and inappropriate bone marrow production. The management of ITP is based on the utilization of steroids, intravenous immunoglobulins, rituximab, thrombopoietin receptor agonists (TPO-RAs), immunosup...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med
Main Authors: Audia, Sylvain, Bonnotte, Bernard
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958340/
https://ncbi.nlm.nih.gov/pubmed/33801294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051004
Tags: Add Tag
No Tags, Be the first to tag this record!